Back
Full-text
Journal article

COVID-19 and Cancer: Current Challenges and Perspectives.

  • Bakouny Z Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Hawley JE Division of Hematology and Oncology, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY, USA.
  • Choueiri TK Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Peters S Oncology Department, CHUV, Lausanne, Vaud, Switzerland.
  • Rini BI Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Warner JL Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA; Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Painter CA Cancer Program, Broad Institute of MIT and Harvard, 415 Main Street, Cambridge, MA 02142, USA. Electronic address: painter@broadinstitute.org.
Show more…
  • 2020-10-13
Published in:
  • Cancer cell. - 2020
COVID-19
cancer
cancer research
pandemic
Betacoronavirus
Coronavirus Infections
Delivery of Health Care
Humans
Neoplasms
Pandemics
Pneumonia, Viral
English Patients with cancer have been disproportionately affected by the COVID-19 pandemic. This effect has included the adverse outcomes in patients with cancer who develop COVID-19, the impact of the COVID-19 pandemic on the delivery of cancer care, and the severe disruption to cancer research. However, patients with cancer are a heterogeneous population, and recent studies have now documented factors that allow risk stratification of patients with cancer in order to optimize care. In this review, we highlight data at the intersection of COVID-19 and cancer, including the biological interplay between the two diseases and practical recommendations for the treatment of patients with cancer during the pandemic. We additionally discuss the potential long-lasting impact of the pandemic on cancer care due to its deleterious effect on cancer research, as well as biological insights from the cancer research community that could help develop novel therapies for all patients with COVID-19.
Language
  • English
Open access status
bronze
Identifiers
Persistent URL
https://folia.unifr.ch/global/documents/213206
Statistics
Document views: 15 File downloads:
  • fulltext.pdf: 0